CONTRACT RESEARCH AGREEMENT CDT INTERNATIONAL LIMITED (1) AND COVION ORGANIC SEMICONDUCTORS GMBH (2)Contract Research Agreement • December 15th, 2004 • Cambridge Display Technology, Inc. • Semiconductors & related devices • England
CONFIDENTIAL TREATMENT REQUESTED: INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED FROM THIS DOCUMENT. SUCH OMISSIONS ARE NOTED BY “[**]”. AN UNREDACTED VERSION OF THIS DOCUMENT HAS BEEN SUBMITTED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION.
EX-10.2 3 dex102.htm CONTRACT RESEARCH AGREEMENT EXECUTION COPY [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE...Contract Research Agreement • May 5th, 2020 • New York
This CONTRACT RESEARCH AGREEMENT (this “Agreement”) is made and entered into as of the Effective Date (as defined below), by and among AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”), MYCOGEN CORPORATION, a California corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Mycogen”), EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”), and EXELIXIS, INC., a Delaware corporation having its principal place of business at 170 Harbor Way, P.O. Box 511, South San Francisco, California 94083 (“Exelixis”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Mycogen is a party to this Agreement solely pursuant to Sections 9.4, 9.5, 9.6 and 11.1 and as a guarantor pursuant t
CONTRACT RESEARCH AGREEMENTContract Research Agreement • November 25th, 2020
COMPANY, with its registered office at ...., legal person no. ..., registered in the Company Register under no. ..., represented by ...., hereinafter referred to as the COMPANY;
CONTRACT RESEARCH AGREEMENTContract Research Agreement • October 31st, 2014 • Enumeral Biomedical Holdings, Inc. • Pharmaceutical preparations
Crucell Holland B.V., a private company with limited liability, with offices located at Archimedesweg 4, 2333 CN Leiden, the Netherlands, (“Crucell”),
CONTRACT RESEARCH AGREEMENT (WITH COMMENTS)Contract Research Agreement • August 1st, 2020
This justifies the full allocation of the intellectual property rights to the company for the technological solution developed by the R&D partner and the tighter restriction of the rights of the latter in comparison to, for example, the M5 draft for R&D collaboration between the same partners (which offers the chance of R&D Partner rights ownership or, more remotely, co-ownership).
FIFTH AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • October 29th, 2009 • Exelixis Inc • Services-commercial physical & biological research • Delaware
This FIFTH AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
FIRST AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research
This FIRST AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
ContractContract Research Agreement • January 12th, 2021
CONTRACT RESEARCH AGREEMENTContract Research Agreement • November 3rd, 2021
OPTION A a) The PRINCIPAL is interested in the execution of a research regarding ;b) The ADMINISTRATIVE UNIT, as part of its institutionalactivity, is currently carrying out studies and research related to
CONTRACT RESEARCH AGREEMENTContract Research Agreement • March 7th, 2016
made, on the day, month and year mentioned below and pursuant to Section 1746, Para 2, Act No 89/2012, Civil Code, this Agreement (hereinafter “this Agreement”):
CONTRACT RESEARCH AGREEMENTContract Research Agreement • November 8th, 2022 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
This Contract Research Agreement (this “Agreement”) is entered into by and between the following parties on July 5, 2022 (the “Effective Date”):
CONTRACT RESEARCH AGREEMENT between [Insert full contractual designation of University] andContract Research Agreement • March 30th, 2021
[ ] LIMITED, incorporated in [Scotland] under the Companies Acts (company number [ ]) and having its registered office at [ ] (the “Company”)
Contract Research AgreementContract Research Agreement • December 16th, 2005 • Virexx Medical Corp • Biological products, (no disgnostic substances) • Alberta
This Contract Research Agreement (“Agreement”) is made effective this 15th day of November, 1998, by and between the Board of Governors of the University of Alberta on behalf of the Noujaim Institute for Pharmaceutical Oncology Research, (the “Institute”), Faculty for Pharmacy and Pharmaceutical Sciences, University of Alberta (the “University”), of the first part, and Noustar Technologies Inc., and Somagen Diagnostics Inc., collectively, of the second part, (“the Joint Venture”).
CONTRACT RESEARCH AGREEMENTContract Research Agreement • September 11th, 2020 • Aptorum Group LTD • Pharmaceutical preparations • Hong Kong
WHEREAS, Aeneas is a technology company that is in the business of developing and providing technology and software solutions.
Portions of this document have been redacted pursuant to a Request for Confidential Treatment filed with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. Redacted portions are...Contract Research Agreement • August 7th, 2014 • Enumeral Biomedical Holdings, Inc. • Services-computer programming, data processing, etc.
Crucell Holland B.V., a Dutch company with offices located at Archimedesweg 4-6, 2333 CN Leiden, the Netherlands, hereinafter referred to as “Crucell”; and
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS ([***]), HAS BEEN OMITTED BECAUSE THE INFORMATION (I) IS NOT MATERIAL ANDContract Research Agreement • May 9th, 2023 • Amphastar Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment to the Contract Research Agreement (this “Amendment”) is entered into by and between the following parties on March 8, 2023:
SECOND AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • March 10th, 2009 • Exelixis Inc • Services-commercial physical & biological research
This SECOND AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
WITNESSETH:Contract Research Agreement • March 30th, 2000 • Carrington Laboratories Inc /Tx/ • Pharmaceutical preparations • Texas
CONTRACT RESEARCH AGREEMENTContract Research Agreement • April 24th, 2015
made, on the day, month and year mentioned below and pursuant to Section 1746, Para 2, Act No 89/2012, Civil Code, this Agreement (hereinafter “this Agreement”):
THIRD AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • December 18th, 2009 • Exelixis Inc • Services-commercial physical & biological research
This THIRD AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
FOURTH AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • December 18th, 2009 • Exelixis Inc • Services-commercial physical & biological research
This FOURTH AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
Model AgreementsContract Research Agreement • October 1st, 2018
The Model Agreements were prepared under the direction and management of Ms. Olga Spasić (Project Leader) and authored by Mr. D. Patrick O'Reilley.
THIRD AMENDMENT TO THE CONTRACT RESEARCH AGREEMENTContract Research Agreement • July 30th, 2009 • Exelixis Inc • Services-commercial physical & biological research
This THIRD AMENDMENT TO THE CONTRACT RESEARCH AGREEMENT (the “Amendment”) is made and entered into by and between AGRIGENETICS, INC., a Delaware corporation having its principal place of business at 9330 Zionsville Road, Indianapolis, Indiana 46268 (“Agrigenetics”) and EXELIXIS PLANT SCIENCES, INC., a Delaware corporation having its principal place of business at 16160 SW Upper Boones Ferry Road, Portland, Oregon 97224 (“EPS”). Agrigenetics and EPS are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
CONTRACT RESEARCH AGREEMENTContract Research Agreement • March 21st, 2017 • Microbot Medical Inc. • Biological products, (no disgnostic substances) • New York
This Contract Research Agreement is entered into as of this __ day of _________, 2017 (the “Effective Date”), by and between The Washington University, a corporation established by special act of the Missouri General Assembly approved February 22, 1853 and acts amendatory thereto, having its principal offices at One Brookings Drive, St. Louis, Missouri 63130 (“University”) and Microbot Medical Ltd., a company formed under the laws of Israel, with offices at 5 Hamada Street, Yokneam, Israel (the “Company”).
Model AgreementsContract Research Agreement • July 8th, 2021
The Model Agreements were prepared under the direction and management of Ms. Olga Spasić (Project Leader) and authored by Mr. D. Patrick O'Reilley.
